Endonovo Therapeutics Provides SofPulse® To All NFL Teams
December 23, 2019 08:30 ET | Endonovo Therapeutics, Inc.
Los Angeles, CA, Dec. 23, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), announced today the delivery of SofPulse® evaluation units to all...
Shinkei Logo.png
FDA Accepts SHINKEI Therapeutics Investigational New Drug Application for MR-301 for Traumatic Brain Injury
August 28, 2019 08:00 ET | SHINKEI Therapeutics
PRINCETON, N.J., Aug. 28, 2019 (GLOBE NEWSWIRE) -- SHINKEI Therapeutics., a clinical stage pharmaceutical company focused on the development of therapeutic drugs for the treatment of Central Nervous...
Aptinyx Presents Data Demonstrating Positive Activity of NYX-458 on Cognitive Performance and Biomarkers in a Preclinical Model of Head Injury
August 21, 2019 08:33 ET | Aptinyx Inc.
EVANSTON, Ill., Aug. 21, 2019 (GLOBE NEWSWIRE) -- Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous...
Study Finds First Effective Scalable Intervention for Mild Traumatic Brain Injury
May 16, 2019 07:55 ET | Posit Science
WASHINGTON D.C., May 16, 2019 (GLOBE NEWSWIRE) -- A study run at five military and veterans’ hospitals has identified the first highly-scalable intervention for addressing cognitive deficits that...
Critical Solutions International logo
CSI and BlackBox Biometrics Awarded $6.4 Million Contract for 10,000 Blast Gauge® Systems to Monitor Blast Exposed DoD Personnel
May 15, 2019 09:00 ET | Critical Solutions International
CHARLESTON, S.C., May 15, 2019 (GLOBE NEWSWIRE) -- Critical Solutions International (CSI) and partner BlackBox Biometrics (B3) announced today that the Henry M. Jackson Foundation for the...
Qrons Appoints Dr. Motti Ratmansky as Special Advisor for IND & Clinical Trial Preparations
May 08, 2019 09:00 ET | Qrons Inc.
New York, NY, May 08, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Qrons Inc. (OTC: QRON), an emerging biotechnology company developing advanced stem cell-synthetic hydrogel-based solutions to...
Endonovo Therapeutics Hires Nevena Zubcevik of Harvard Medical School as Chief Medical Officer
May 02, 2019 09:20 ET | Endonovo Therapeutics, Inc.
Los Angeles, CA, May 02, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV), today announced the appointment of Nevena Zubcevik, DO, MSPT, ATC as its chief medical officer starting...
Endonovo Therapeutics Provides Corporate Update
April 26, 2019 08:00 ET | Endonovo Therapeutics, Inc.
LOS ANGELES, CA, April 26, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive Electroceutical™ therapeutic...
Endonovo Therapeutics Announces New Website Launch
February 27, 2019 08:00 ET | Endonovo Therapeutics, Inc.
The completely redesigned website offers visitors deeper insight into the Company's core product, SofPulse® LOS ANGELES, CA, Feb. 27, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB:...
Heuro Canada First to Bring Revolutionary Neurological Health Technology to Canada
December 07, 2018 05:00 ET | Heuro Canada
SURREY, British Columbia, Dec. 07, 2018 (GLOBE NEWSWIRE) -- Heuro Canada Inc., a leading provider of innovative neurological health solutions, is championing a new therapeutic paradigm for...